ROS may also enhance the activation of redox-sensitive transcription factors such as NF-κB and HIF-1, which induce the expression of inflammatory and fibrogenic mediators by Kupffer cells and hepatic stellate cells, thereby aggravating the progression of NAFLD. The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatotic liver disease.